Drugs / LV
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT05969899 Background | Jul 2023 → Jul 2025 overdue | colorectal cancer | Fudan University | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05969899 ↗ |
| Route | Intravenous | “LV 400 mg/m2, iv, for at least 2 hours” NCT05969899 ↗ |